229 related articles for article (PubMed ID: 10868516)
1. New thrombolytic drugs.
Thomson A
Aust N Z J Med; 1999 Jun; 29(3):433-5. PubMed ID: 10868516
[TBL] [Abstract][Full Text] [Related]
2. Newer thrombolytic drugs for acute myocardial infarction.
Reddy DS
Indian J Exp Biol; 1998 Jan; 36(1):1-15. PubMed ID: 9536645
[TBL] [Abstract][Full Text] [Related]
3. Newer thrombolytic agents.
Verstraete M
Ann Acad Med Singap; 1999 May; 28(3):424-33. PubMed ID: 10575530
[TBL] [Abstract][Full Text] [Related]
4. [Development of new thrombolytic substances].
Zeymer U; Neuhaus KL
Herz; 1994 Dec; 19(6):314-25. PubMed ID: 7843688
[TBL] [Abstract][Full Text] [Related]
5. Thrombolytic agents in development.
Verstraete M; Lijnen HR; Collen D
Drugs; 1995 Jul; 50(1):29-42. PubMed ID: 7588087
[TBL] [Abstract][Full Text] [Related]
6. Remaining perspectives of mutant and chimeric plasminogen activators.
Lijnen HR; Collen D
Ann N Y Acad Sci; 1992 Dec; 667():357-64. PubMed ID: 1309056
[TBL] [Abstract][Full Text] [Related]
7. Thrombolytic and pharmacokinetic properties of a conjugate of recombinant single-chain urokinase-type plasminogen activator with a monoclonal antibody specific for cross-linked fibrin in a baboon venous thrombosis model.
Collen D; Dewerchin M; Rapold HJ; Lijnen HR; Stassen JM
Circulation; 1990 Nov; 82(5):1744-53. PubMed ID: 2121385
[TBL] [Abstract][Full Text] [Related]
8. New developments in thrombolytic therapy.
Collen D; Gold HK
Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
[TBL] [Abstract][Full Text] [Related]
9. The search for the ideal thrombolytic agent.
Verstraete M
J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):4B-10B. PubMed ID: 2959714
[TBL] [Abstract][Full Text] [Related]
10. Thrombolytic therapy.
Collen D; Stump DC; Gold HK
Annu Rev Med; 1988; 39():405-23. PubMed ID: 3130773
[TBL] [Abstract][Full Text] [Related]
11. New thrombolytic agents and strategies.
Collen D; Lijnen HR
Baillieres Clin Haematol; 1995 Jun; 8(2):425-35. PubMed ID: 7549072
[TBL] [Abstract][Full Text] [Related]
12. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.
Lu HR; Wu Z; Pauwels P; Lijnen HR; Collen D
J Am Coll Cardiol; 1992 May; 19(6):1350-9. PubMed ID: 1342779
[TBL] [Abstract][Full Text] [Related]
13. Thrombolytic profiles of clot-targeted plasminogen activators. Parameters determining potency and initial and maximal rates.
Holvoet P; Dewerchin M; Stassen JM; Lijnen HR; Tollenaere T; Gaffney PJ; Collen D
Circulation; 1993 Mar; 87(3):1007-16. PubMed ID: 8443877
[TBL] [Abstract][Full Text] [Related]
14. [New thrombolytic agents in myocardial infarction].
Charbonnier B; Lang M; Brochier M
Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
[TBL] [Abstract][Full Text] [Related]
15. Third-generation thrombolytic drugs.
Verstraete M
Am J Med; 2000 Jul; 109(1):52-8. PubMed ID: 10936478
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanism of action of newer thrombolytic agents.
Collen D
J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):11B-15B. PubMed ID: 3117858
[TBL] [Abstract][Full Text] [Related]
17. New strategies in the development of thrombolytic agents.
Lijnen HR; Collen D
Blut; 1988 Oct; 57(4):147-62. PubMed ID: 3139109
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotic effects of thrombolytic agents in a platelet-rich femoral vein thrombosis model in the hamster.
Stassen JM; Nyström A; Hoylaerts M; Collen D
Circulation; 1995 Mar; 91(5):1330-5. PubMed ID: 7867170
[TBL] [Abstract][Full Text] [Related]
19. Current developments in thrombolytic therapy using novel plasminogen activators.
Seifried E; Tanswell P
Arzneimittelforschung; 1989 Nov; 39(11):1474-82. PubMed ID: 2695093
[TBL] [Abstract][Full Text] [Related]
20. Coronary thrombolysis with clot-selective plasminogen activators.
Collen D; Bounameaux H
Herz; 1986 Feb; 11(1):9-15. PubMed ID: 3082731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
